Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

bcb907af9e5392b6b6c5e6338d6d39f8.n5wWC56w4rdj58rqlXto60MjGkq6GO1TfQd48A5vWaY.rKpuYazR04VQ35u5wjNYhndzQAXYLNo3REkaqEpCHPCvzW5u2tWMhjGyrQ~45faa5e7e785335dbe657b5c375cab54
09-11 Berenberg Notes AstraZeneca's 'Stellar' Tozorakimab Late-stage Data; Buy Retained MT
09-10 AstraZeneca PLC : Gets a Sell rating from Deutsche Bank ZD
09-10 AstraZeneca PLC : Berenberg reiterates its Buy rating ZD
09-09 RBC Capital Markets Initiates AstraZeneca Coverage at Outperform MT
09-09 RBC Initiates AstraZeneca at Outperform With GBP145 Price Target MT
09-09 RBC prefers Astra to GSK; HSBC cuts Burberry AN
09-09 RBC Initiates AstraZeneca at Outperform as Near-term Overhangs Create 'Attractive' Entry Point MT
09-09 AstraZeneca PLC : Gets a Buy rating from RBC ZD
09-08 AstraZeneca PLC : Buy rating from JP Morgan ZD
09-08 AstraZeneca PLC : Receives a Sell rating from Deutsche Bank ZD
09-08 Jefferies raises Autotrader and Rightmove AN
09-08 AstraZeneca PLC : Barclays maintains a Buy rating ZD
09-07 BofA Upbeat on AstraZeneca's Camizestrant After US Approval Based on Serena-6 Trial Results MT
09-07 AstraZeneca PLC : Gets a Buy rating from JP Morgan ZD
09-07 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
09-04 AstraZeneca: Share price weakness of late, should be capitalised on Alphavalue
09-03 AstraZeneca Kept at Buy as Berenberg Notes Upcoming COPD Data Readout MT
09-02 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
09-01 AstraZeneca PLC : JP Morgan reaffirms its Buy rating ZD
08-28 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
08-25 AstraZeneca PLC : Gets a Sell rating from Deutsche Bank ZD
08-24 JPMorgan raises Diploma, Barclays cuts Unite AN
08-20 Cancer vaccines finally garner the spotlight Alphavalue
08-20 Goldman likes Astra; JPMorgan lowers Trainline AN
08-20 AstraZeneca PLC : Goldman Sachs reaffirms its Buy rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.42%
+4.34%
+8.75%
+8.17%
+11.56%
+33.47%
+1.45%
+8.34%
+9.21%
Average +11.41%
Weighted average by Cap. +11.86%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
159.06USD
Average target price
212.30USD
Spread / Average Target
+33.47%
High Price Target
273.62USD
Spread / Highest target
+72.02%
Low Price Target
151.95USD
Spread / Lowest Target
-4.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!